Skip to content

Neural mechanisms underlying cardiovascular dysfunction induced by chronic pain

Neural mechanisms underlying cardiovascular dysfunction induced by chronic pain

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2600131083
Enrollment
Unknown
Registered
2026-08-28
Start date
2026-08-30
Completion date
Unknown
Last updated
2026-08-31

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic pain

Interventions

Control group:None

Sponsors

Linyi People's Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
30 Years to No maximum

Inclusion criteria

Inclusion criteria: 1. Inclusion criteria for the case group: aged =30 years; American Society of Anesthesiologists (ASA) physical status classification grade ??; clinically diagnosed with neuropathic pain; body mass index (BMI) between 18 and 30 kg/m². 2. Inclusion criteria of the control group: age =30 years; physical examination showing "healthy" or "no obvious abnormalities"; absence of cardiovascular diseases (hypertension, coronary heart disease, arrhythmia, heart failure, valvular heart disease); no diabetes, severe liver/renal dysfunction, or malignant tumors that may affect cardiovascular condition; no recent use of drugs affecting blood pressure, heart rate or cardiac function (ß-blockers, calcium antagonists, ACEIs/ARBs).

Exclusion criteria

Exclusion criteria: 1. Exclusion criteria for the case group: patients complicated with severe cardiovascular and cerebrovascular diseases, hepatic or renal insufficiency, or severe arrhythmia; patients with a history of psychiatric disorders or long-term use of psychotropic drugs; patients with malignant tumors. 2. Exclusion criteria of the control group: acute pain within 1 month (trauma, post-operative, acute toothache, acute abdominal pain) requiring analgesia; any analgesic use within 2 weeks (NSAIDs, opioids, acetaminophen, topical analgesic patches); presence of chronic pain (arthritis, postherpetic neuralgia, diabetic peripheral neuropathy, sciatica, trigeminal neuralgia, post-spinal cord injury chronic pain, migraine, visceral pain).

Design outcomes

Primary

MeasureTime frame
Blood pressure;Resting heart rate;

Secondary

MeasureTime frame
Visual Analogue Scale for Pain;Laboratory inflammatory markers (e.g., high-sensitivity C-reactive protein, interleukin-6);

Countries

China

Contacts

Public ContactPei Shi

Linyi People's Hospital

1354090806@qq.com+86 539 8618328

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Sep 19, 2026